CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

IntroductionAlzheimer’s disease (AD) is the most prevalent form of dementia with symptoms of deteriorating cognitive functions and memory loss, partially as a result of a decrease in cholinergic neurotransmission. The disease is incurable and treatment with cholinesterase inhibitors (ChEIs) is sympt...

Full description

Bibliographic Details
Main Authors: Azadeh Karami, Taher Darreh-Shori, Marianne Schultzberg, Maria Eriksdotter
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer’s disease (AD)
choline acetyltransferase (ChAT)
acetylcholinesterase (AChE)
amyloid beta (Aβ)
Cholinergic Index
mild cognitive impairment (MCI)
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.704583/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.704583/full

Similar Items